It looks like Apple’s CEO had a liver transplant about two months ago in Tennessee. Steve Jobs will apparently return to work sometime later this month. Will Apple host a special event featuring Jobs at the end of June as it was speculated before?

Here’s what the Wall Street Journal is saying about the liver transplant:

William Hawkins, a doctor specializing in pancreatic and gastrointestinal surgery at Washington University in St. Louis, Mo., said that the type of slow-growing pancreatic tumor Mr. Jobs had will commonly metastasize in another organ during a patient’s lifetime, and that the organ is usually the liver. “All total, 75% of patients are going to have the disease spread over the course of their life,” said Dr. Hawkins, who has not treated Mr. Jobs.

Getting a liver transplant to treat a metastasized neuroendocrine tumor is controversial because livers are scarce and the surgery’s efficacy as a cure hasn’t been proved, Dr. Hawkins added. He said that patients whose tumors have metastasized can live for as many as 10 years without any treatment so it is hard to determine how successful a transplant has been in curing the disease.

We wish all the best to Steve Jobs and we’ll be waiting to see what wild Apple products he will come up with next. When he’s good and ready of course!

via WSJ

Tags: Apple, CEO, Mobile News, steve jobs, Wall Street Journal